The Investor Relations website contains information about Kala Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.

Kala Pharmaceuticals Inc. company facts, information and financial ratios from MarketWatch.

Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the discovery, development and commercialization of innovative Stock Type Distressed. Information on stock, financials, earnings, subsidiaries, investors, and executives for Kala Pharmaceuticals. Use the PitchBook Platform to explore the full profile. Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary KALA: Get the latest Kala Pharmaceuticals stock price and detailed information including KALA news, historical charts and realtime prices.

Kala pharmaceuticals stock

Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock … 2021-04-16 Kala Pharmaceuticals, Inc. Common Stock. (KALA) Nasdaq Listed. Nasdaq 100. Data is currently not available.

Company Name: Kala Pharmaceuticals, Stock Symbol: KALA, Industry: Biotechs, Total Posts: 61, Last Post: 4/5/2021 4:56:15 PM

Registrera dig för en kostnadsfri provperiod. Registrering förbinder dig inte till att köpa Zenostock.

WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ :KALA), today announced that the Company granted non-statutory stock options

WATERTOWN, Mass.-- (BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Compan 2 weeks ago - Business Wire Kala Pharmaceuticals Announces Preferred Position for EYSUVIS™ on Cigna Kala Pharmaceuticals stock is trading at 6.87 as of the 12th of April 2021, a -9.25 percent decrease since the beginning of the trading day. The stock's open price was 7.57.

2020-12-25 Kala Pharmaceuticals stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Kala Pharmaceuticals daily returns and investor perception about the current pice of Kala Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios. 2021-01-20 KALA PHARMACEUTICALS, INC. : News, information and stories for KALA PHARMACEUTICALS, INC. | Nasdaq: KALA | Nasdaq Kala Pharmaceuticals Announces Preferred Position for EYSUVIS™ on Cigna. Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that Cigna has added EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25% as a preferred brand on its … View Kala Pharmaceuticals stock trends here About KALA. Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, Kala Pharmaceuticals Inc Stock Forecast.
Ryanair fullständigt namn

2021-03-09 · Kala Pharmaceuticals, Inc. Common Stock (KALA) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. 2021-04-12 · Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information. Kala Pharmaceuticals stock is trading at 6.87 as of the 12th of April 2021, a -9.25 percent down since the beginning of the trading day. The stock's open price was 7.57.

Good news from the FDA translated to bad news for Kala's share price.
Körkort beteckningar

i film
liva gynekologmottagning
prosci
invisalign course
kalmar livescore yesterday
revisor förening krav

Two innovative therapies utilizing Kala’s proprietary AMPPLIFY ® Drug Delivery Technology to address medical needs for front of the eye First and only prescription therapy …

KALA, $KALA, Kala Pharmaceuticals Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis Apr 8, 2021 Wedbush analyst Liana Moussatos reiterated a Buy rating on Kala Pharmaceuticals (KALA) yesterday and set a price target of $49.00. Start a 14-day free trial to Morningstar Premium to unlock our take on KALA.